ABSTRACT: A Taura syndrome virus (TSV) isolate from cultured Penaeus vannamei grown in Belize, Central America was characterized and shown to be a unique isolate. Mortality rates in laboratory infections of specific pathogen-free (SPF) P. vannamei, reactivity of the virus with monoclonal antibody (MAb) 1A1 and phylogenetic analysis demonstrated that the Belize isolate (BLZ02TSV) is a new variant of TSV. The Hawaiian 1994 TSV isolate (HI94TSV, GenBank AF277675) was used as the reference isolate for these studies. Laboratory infections of SPF P. vannamei with BLZ02TSV demonstrated higher mortalities and earlier onset of mortalities compared to infections with HI94TSV. Shrimp tissues infected with BLZ02TSV reacted with a TSV-specific gene probe by in situ hybridization and were positive by RT-PCR using TSV diagnostic primers, thus indicating that the isolate was TSV. However, Western blot analysis and immunohistochemistry using MAb 1A1 demonstrated that BLZ02TSV did not react with the antibody, suggestive of changes in the VP1 region of the genome that codes for the polypeptide to which MAb 1A1 binds. Phylogenetic analysis of a 1.3 kbp fragment of the TSV VP1 capsid region revealed that BLZ02TSV represents a distinct group among more than 29 isolates of TSV studied thus far. This research demonstrates that BLZ02TSV is a unique isolate of TSV and reiterates a problem related to the use of MAb 1A1 for detection of TSV in clinical specimens.
INTRODUCTION
Taura syndrome (TS), first recognized in Ecuador affecting Penaeus vannamei (Jimenez 1992 , Lightner et al. 1995 , is now known to occur in most shrimpfarming countries in the Americas, and recently has spread to Taiwan, China, Thailand and Indonesia with the importation of P. vannamei for shrimp culture (Chien et al. 1999 , Tu et al. 1999 , Yu & Song 2000 , Lien et al. 2002 . Concomitant with the rapid spread of disease among shrimp populations is the possibility of genetic variations occurring within the viral genome (Alday de Graindorge 2003) . Indeed, during 1999 through 2000, reports from the industry indicated that Taura syndrome virus (TSV) was causing significant mortalities in P. stylirostris, a penaeid species once believed refractory to acute TS disease (Erickson et al. 2002 , Robles-Sikisaka et al. 2002 . Also, during 2001 through 2002, the shrimp industry reported on TS epizootics in Belize, Central America, of a severity not seen in western penaeid aquaculture since the initial TS epizootics (Rosenberry 2002) .
TSV, the etiologic agent of TS, is a single stranded RNA virus recently classified as a species in the genus Cripavirus within the family Dicistroviridae (Bonami et al. 1997 , Mayo 2002a . Mari et al. (2002) sequenced the Hawaiian isolate of TSV (HI94TSV) and determined that the genome is 10 205 bases in length and identified the positions of the coding regions for the capsid proteins VP1 (55 kDa), VP2 (40 kDa) and VP3 (24 kDa) by direct NH 2 -terminal amino acid sequencing of the polypeptides (Mari et al. 2002; GenBank AF277675) . The only commercially available monoclonal antibody (MAb) to TSV, designated MAb 1A1 (DiagXotics), recognizes an antigenic epitope within VP1 (Poulos et al. 1999) . Erickson et al. (2002) examined 4 selected TSV isolates from the US and Mexico and demonstrated that there were differences in the ability of 1 of the isolates to react with TSV-specific MAb 1A1. In another study, 2 isolates of TSV from Mexico and Nicaragua also failed to react with MAb 1A1 in paraffin-embedded sections (Robles-Sikisaka et al. 2002) . In both studies, the coat protein region of the virus was implicated in the serological differences, which is reasonable since the MAb was shown to react specifically with VP1 by Western blot analysis (Poulos et al. 1999) .
Reported here are studies comparing the TSV isolate from Belize (BLZ02TSV) with the reference isolate from Hawaii (HI94TSV). In laboratory bioassay studies, the BLZ02TSV isolate appeared to be more virulent than the reference HI94TSV isolate, supporting industry reports of increased virulence of the BLZ02TSV isolate. The BLZ02TSV isolate was shown to react with the diagnostic TSV primer set in RT-PCR and to yield strong positive signals using the TSV-specific gene probe in the in situ hybridization test. Significantly, the BLZ02TSV isolate failed to react in a Western blot or by immunohistochemistry (IHC) using MAb 1A1. Sequencing and phylogenetic analysis of the VP1 region indicates that BLZ02TSV is distinct from other isolates of TSV studied to date. These findings demonstrate that the isolate from Belize is distinct from the reference isolate and should be classified as a unique variant which displays increased virulence and shows no reactivity to MAb 1A1 by Western blot or IHC.
MATERIALS AND METHODS

Shrimp. Specific pathogen-free (SPF) Kona stock
Penaeus vannamei were obtained from the Oceanic Institute's SPF breeding program in Hawaii and were used for generation of TSV and for laboratory bioassays (Wyban et al. 1992 , Lotz 1997 . The shrimp were reared and maintained at the University of Arizona Aquaculture Pathology Laboratory (UAZAPL) according to the protocol of White et al. (2002) . Shrimp taxonomy used in this paper is according to Holthius (1980) . Virus isolates. The viral materials used in these studies were originally collected from Hawaii in 1994 (HI94TSV) and Belize, Central America in 2002 (BLZ02TSV) . The viral isolates from Hawaii and Belize were both purified from Penaeus vannamei. Routine histopathology with hematoxylin and eosin-phloxine (H&E) staining was used to identify TS in the original isolates (Lightner et al. 1995) . The diagnosis was confirmed using in situ hybridization with TSV-specific gene probes (Mari et al. 1998) .
Bioassays. Experimental quantities of the viruses were prepared and bioassays were performed using SPF Penaeus vannamei (Kona stock) either by per os or injection exposure with infected tissue preparations according to standard methods (Hasson et al. 1995 , White et al. 2002 . Minced tissues for per os bioassays were fed at a rate of 10% of the total body weight of the shrimp for 3 consecutive days. Tissue homogenate for injection was prepared using 1 g infected tissue 5 ml -1 of Tris-NaCl buffer (pH 7), and then diluted 1:10 or 1:20 in 2% (w/v) sterile saline; 10 or 20 µl, respectively were injected g -1 shrimp. Moribund shrimp were collected for histopathology after fixation in Davidson's alcohol-formalin-acetic acid (AFA) or for virus purification after freezing the tissues at -70°C.
Histology. Shrimp preserved in Davidson's AFA were processed for histopathology and observed by light microscopy according to the procedures of Bell & Lightner (1988) .
In situ hybridization. Davidson's AFA-fixed, paraffinembedded shrimp from BLZ02TSV infection used for histology and IHC were also evaluated by in situ hybridization (ISH) utilizing digoxigenin-labeled TSVspecific gene probes P15 and Q1 (Mari et al. 1998) .
Virus purification and electron microscopy. Viral isolate purification was conducted according to the procedure of Bonami et al. (1997) . Viral preparations were examined by transmission electron microscopy (TEM) using 2% phosphotungstic acid as the negative stain and tobacco mosaic virus as the calibrator for size determinations (Bonami et al. 1990) .
Antibodies. Mouse anti-TSV, MAb 1A1, was used as supernatant fluid from hybridoma cells maintained at the UAZ Aquaculture Pathology Laboratory. Mouse polyclonal antibody (PAb) raised against TSV was produced as described by Poulos et al. (1999) . Secondary antibody for detection was a goat anti-mouse IgG (H&L) Fab' 2 -alkaline phosphatase conjugated polyclonal antibody (Zymed Laboratories) diluted 1:500 before use.
IHC on fixed sections. Moribund shrimp, experimentally infected with BLZ02TSV, were fixed and paraffin-embedded according to standard methods (Bell & Lightner 1988) . IHC was performed according to the protocol of Poulos et al. (2001) using MAb 1A1 as the primary antibody. The slides were examined by light microscopy for the presence of a blue-black precipitate in the cytoplasm of TSV infected cells.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Laemmli buffer (Laemmli 1970) containing 10 M urea was used to denature the structural proteins of individual purified TSV isolates prior to separation by SDS-PAGE. Gels were either silver stained (Nielsen & Brown 1984) or electro-transferred to a polyvinylidene difluoride (PVDF) membrane for amino acid (aa) sequencing or nitrocellulose for Western blotting. Transferred proteins were visualized using 0.1% Coomassie blue (Matsudaira 1987) or 0.5% Ponceau red (Nakamura et al. 1985) .
Western blot analysis. The Western blot assay was performed by reacting the nitrocellulose membrane with mouse anti-TSV PAb (diluted 1:500) or with MAb 1A1 (undiluted) as the primary antibody and developed according to the protocol described by Poulos et al. (2001) . Hybridoma cell culture medium was used as a negative control for the primary antibody.
Protein sequencing. Proteins separated on a 10% SDS-PAGE gel were transferred to an Immobilon-P SQ PVDF membrane (0.2 µm pore size). The amino termini (NH 3 + ) of each viral protein were sequenced out for 12 cycles at the UAZ Laboratory for Protein Sequencing and Analyses using an ABI 477A pulsed-liquid protein sequencer (Applied Biosystems).
RT-PCR of purified TSV. The diagnostic TSV-specific oligonucleotide primers that amplify a 231 bp region of the TSV genome were used to confirm the presence of TSV using 1.0 µl of each purified TSV preparation as the template (Nunan et al. 1998 , OIE 2003 . In order to amplify the entire VP1, VP2 and VP3 structural proteincoding regions of the TSV genomes, 6 additional TSVspecific oligonucleotides were developed from the published sequence for Hawaii TSV (GenBank AF277675) based on the starting location of each VP coding region (Mari et al. 2002) (Table 1 ). For amplification of the VP1, VP2 and VP3 coding regions, the Sigma ® enhanced avian RT-PCR kit (Sigma-Aldrich) was utilized and a 1-step RT-PCR amplification of VP1, VP2 and VP3 from purified TSV isolates followed the manufacturer's protocol. Briefly, the RNA template and all the reagents were combined and reverse-transcription was allowed to proceed at 50°C for 45 min, followed by 95°C for 5 min. After reverse-transcription, PCR was allowed to proceed according to the following profile: reactions were amplified for 40 cycles using denaturation at 95°C for 1 min, annealing at 60°C (VP1), 50.6°C (VP2) or 68°C (VP3) for 45 s, and extension at 72°C for 1.5 min. A final extension at 72°C for 5 min followed the last cycle of each PCR profile. RT-PCR products were visualized by standard agarose gel electrophoresis.
Nucleotide sequencing of capsid coding regions. TSV nucleotide sequence data for VP1, VP2 and VP3 coat proteins of BLZ02TSV and VP2 and VP3 of HI94TSV were obtained by sequencing the 1303, 1042, and 671 bp RT-PCR products, respectively, at the UAZ Genomic Analysis and Technology Core on an ABI PRISM ® 377 DNA sequencer with 'XL' upgrades (Applied Biosystems). VP1 from HI94TSV (GenBank AF510518) had been sequenced previously (Erickson et al. 2002) .
RESULTS
Histological, in situ hybridization and immunohistochemical analysis of BLZ02TSV
Histological analysis of moribund shrimp infected with the Belize isolate BLZ02TSV demonstrated pathognomonic acute phase TSV lesions characterized by the classic 'peppered or buckshot appearance' in the cuticular epithelium (Lightner et al. 1995) (Fig. 1A) . The disease status of these shrimp (data not shown) was confirmed by standard RT-PCR using the TSV diagnostic primer set in Table 1 . Further diagnostic testing also confirmed that the Belize isolate was TSV, but was not identical to the HI94TSV reference isolate. A comparison of serial tissue sections of BLZ02TSV-infected shrimp processed for ISH and IHC demonstrated that this isolate could be detected by routine ISH with TSV-specific gene probes P15 and Q1 (Fig. 1B) , but could not be detected by IHC with TSV MAb 1A1 (Fig. 1D) , although the positive control tissue (HI94) included in the assay was reactive with MAb 1A1 (Fig. 1C) .
TEM confirmation of BLZ02TSV isolate
Virions purified from the Belize isolate were examined by TEM (data not shown) and their size and shape were determined to be consistent with virions purified from HI94TSV-infected tissues. Size analysis using tobacco mosaic virus as the calibrator demonstrated that 93 the average size of the BLZ02TSV virus particles was 32.693 ± 1.834 nm compared to the average size of the HI94TSV virus particles that was 31.485 ± 1.187 nm.
Bioassays of BLZ02TSV and HI94TSV
Because of industry reports indicating that the BLZ02TSV isolate was causing higher mortalities than seen previously with TSV, bioassays were conducted to compare the disease course of the infection with that due to the reference HI94TSV isolate. Both injection and per os bioassays were performed using SPF Penaeus vannamei (Kona stock). Table 2 shows the results of 8 different bioassays performed from 2002 to 2004 comparing BLZ02TSV and HI94TSV infections. Since there are no known cell culture systems that support the growth of TSV (Pantoja et al. 2004) , it was not possible to titer the inoculum preparations that were used. However, the minced and 
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homogenized tissues were prepared using shrimp that were infected at a Grade 3 to 4 level, as assessed by histology. The results indicate that in infections due to BLZ02TSV, mortalities tend to occur earlier (in 5 of the 8 bioassays performed) and result in fewer survivors (in 8 of the 8 bioassays) than with infections due to HI94TSV.
SDS-PAGE analysis
By SDS-PAGE analysis, BLZ02TSV appeared similar to the HI94TSV isolate ( Fig. 2A) . The silver stained gel demonstrated that the virus preparations of HI94TSV and BLZ02TSV contained similar amounts of protein and these preparations were used to prepare the membranes for Western blot analysis.
Antigenic reactivity by Western blot and immunohistochemistry
MAb 1A1 reacts with VP1 of the HI94TSV isolate (Poulos et al. 2001 ). However, no reaction was seen with MAb 1A1 when reacted with BLZ02TSV, and the reaction of the mouse PAb with BLZ02TSV was much weaker than the reaction seen with HI94TSV (Fig. 2C) .
Comparison of the bands in the parallel silver stained SDS-PAGE gel ( Fig. 2A) and Ponceau red staining of the membrane after electro-transfer (Fig. 2B) demonstrated that the concentrations of the transferred polypeptides in the BLZ02TSV and HI94TSV isolates were similar; therefore, the lack of reactivity with MAb 1A1 was not due to less protein in the preparation. This observation that MAb 1A1 does not react to BLZ02TSV in Western blot was corroborated by the lack of reac-95 A B C tivity with BLZ02TSV in IHC using MAb 1A1 (Fig. 1D) . Hence, there is an antigenic difference between HI94TSV and BLZ02TSV within the VP1 region of the capsid protein that is recognized by MAb 1A1.
RT-PCR amplification and nucleotide sequencing of regions encoding VP1, VP2 and VP3
The primers listed in Table 1 were used to amplify the VP coding regions of the TSV isolates. The sequencing of VP1 for the HI94TSV reference isolate (GenBank AF510518) was previously reported by Erickson et al. (2002) , but none of the other VP regions from this isolate had been amplified previously. The expected bands were amplified from both isolates based on size estimates from the agarose gel of the products (data not shown). The nucleotide sequence of each VP fragment was sequenced and the sequences were deposited in GenBank (AY826051, AY826052, AY826053, AY826054, AY826055). The nucleotide sequences of the VP fragments from BLZ02TSV demonstrated between 95 and 99% identity with HI94TSV VP fragments.
Protein sequencing
The NH 2 -terminal amino acids (aa) from the VP proteins of the BLZ02TSV isolate were sequenced. The first 12 aa of the BLZ02TSV and HI94TSV isolates were the same for VP1 (SKDRDMTKVNAY), VP2 (ANPVEI-DNFDTT) and VP3 (AGLDYSSSDTST), confirming that the protein bands visualized by SDS-PAGE were indeed VP1, VP2 and VP3 for the 2 isolates. The remaining downstream aa sequences were derived from the nucleotide sequence for each VP. Fig. 3 shows the derived aa sequence for VP1 of BLZ02TSV compared with the HI94TSV reference sequence. The derived aa sequence of BLZ02TSV VP1 showed 96% identity with the VP1 sequence of HI94TSV. The VP2 and VP3 derived aa sequences are not shown, but can be deduced from the GenBank nucleotide sequences. BLZ02TSV VP2 contained 3 aa substitutions compared to HI94TSV VP2, whereas BLZ02TSV VP3 was 100% identical to HI94TSV. By SDS-PAGE analysis, BLZ02TSV was shown to possess 3 major structural proteins consistent with the pattern seen with HI94TSV. Notably, no reaction was seen with VP1 from BLZ02TSV when the separated proteins were reacted with MAb 1A1 in a Western blot. The lack of reactivity to MAb 1A1 was also seen in IHC tests, wherein MAb 1A1 failed to react to TSV lesions in tissue sections from BLZ02TSV-infected shrimp. Therefore, the antigenicity of the VP1 protein from BLZ02TSV differs from that of the VP1 of HI94TSV. A TSV isolate from Sinaloa, Mexico, in 1998 (SIN98TSV) was similarly shown not to react with MAb 1A1 in Western blots or IHC (Erickson et al. 2002) . A TSV isolate from Sonora, Mexico, and an isolate from Nicaragua were also shown by Robles-Sikisaka et al. (2002) not to react with MAb 1A1 in IHC. Taken together, these results indicate that caution must be used when diagnosing TSV using serological tests that incorporate MAb 1A1.
DISCUSSION
In order to further elucidate the differences in the BLZ02TSV isolate, the genes encoding the viral coat proteins were amplified and sequenced. The starting points of the coding regions for each VP of BLZ02TSV were confirmed by direct NH 2 -terminal aa sequencing of the proteins and all the proteins were shown to be identical to the HI94TSV proteins in their first 12 aa. Primers for VP1 started approximately 30 bp upstream from the first codon of VP1 and ended 100 bp prior to the start of VP3. VP2 primers started 100 bp upstream of the first codon of VP2 and ended 75 bp prior to the start of VP1. VP3 primers started 100 bp upstream of the VP3 start codon and ended at the stop codon for ORF2. These primers differ significantly from those utilized by Robles-Sikisaka et al. (2002) in their analysis of TSV geographic isolates, but the VP1 primers are identical to those used in the phylogenetic analysis by Tang et al. (2004) . When the BLZ02TSV VP1, VP2 and VP3 coding regions were compared to the nucleotide sequence for these regions in HI94TSV, VP1 showed the most variability, although similarities for all regions were in the range of 96 to 100%. When Tang et al. (2004 and pers. comm .) compared VP1 from 29 TSV isolates from the Americas and Asia, they demonstrated that the BLZ02TSV isolate, as well as 2 other isolates from Belize in 2003 and , are distinct from all the other isolates of TSV studied to date.
The data presented here indicate the presence of a new variant of TSV. It is not surprising that TSV, a single stranded RNA virus that infects thousands of individuals in each epizootic, has demonstrated mutations in the structural protein region. These changes are significant from a diagnostic standpoint since they are manifested by a loss of reactivity to the only monoclonal antibody available for testing. The data corroborates conclusions made by others (Erickson et al. 2002 , Robles-Sikisaka et al. 2002 that MAb 1A1-based methods may not detect all TSV isolates and highlights the need to use more than 1 test prior to reporting the diagnosis of a particular disease. It is noteworthy that the OIE-designated TSV-specific primers and the gene probe for ISH (OIE 2003) have detected all suspected isolates of TSV studied to date at the UAZ Aquaculture Pathology Laboratory and hence may be the most useful as confirmatory tests for the presence or absence of TSV in clinical specimens.
